Medpace Holdings, Inc. (MEDP) Downgraded to Neutral by Baird

Market Context

Medpace Holdings, Inc. operates in the Healthcare sector. The stock currently trades at $530.02 with a market capitalization of $15.9B. The stock has gained 73.3% over the past 52 weeks.

Analyst downgrades can weigh on a stock in the short term as institutional investors who follow Baird's research adjust their positions. However, downgrades also sometimes create buying opportunities if the market overreacts to the rating change. The reasoning behind the downgrade matters more than the rating itself.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Medpace Holdings, Inc.

Among the 10 most recent ratings: 4 Buy, 6 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jul 08, 2026	Baird	Neutral	N/A
Jul 07, 2026	Jefferies	Hold	N/A
Apr 24, 2026	Barclays	Equal-Weight	N/A
Apr 24, 2026	BMO Capital	Market Perform	N/A
Apr 24, 2026	RBC Capital	Outperform	N/A

Related Tools: Analyst Ratings Dashboard | View MEDP Stock Page